Octanoate-containing emulsion

Abstract

Cosmetic preparation containing a) Glyceryl stearate citrate and b) 2-Propylheptyloctanoate.

Description

[0001] The present invention relates to a combination of glyceryl stearate citrate and 2-propylheptyl octanoate.

[0002] The desire to look beautiful and attractive is deeply rooted in human nature. Although the ideal of beauty has changed over time, the pursuit of a flawless appearance has always been a human goal. The condition and appearance of the skin plays a significant role in achieving a beautiful and attractive appearance.

[0003] In order for the skin to fully fulfill its biological functions, it requires regular cleansing and care. Cleansing the skin removes dirt, sweat, and dead skin particles, which provide an ideal breeding ground for pathogens and parasites of all kinds. Skin care products typically serve to moisturize and replenish the skin's oils. They often contain active ingredients designed to regenerate the skin and, for example, prevent or reduce premature aging (e.g., the formation of fine lines and wrinkles).

[0004] The skin requires both lipid-based and water-soluble care ingredients. Therefore, today's skin care products typically contain an oil / fat body and a water phase.

[0005] Fats and oils are naturally immiscible with water and water-soluble substances (e.g., salts). To obtain a visually homogeneous, stable preparation from the water and oil phases, surface-active additives (emulsifiers) must be added. These additives are capable of dispersing tiny oil and solid globules in water (oil-in-water emulsion, O / W emulsion) or water droplets in oils (water-in-oil emulsion, W / O emulsion). The resulting emulsions allow for "2-in-1" skin care with water- and oil-soluble substances. Depending on their consistency, they are referred to as ointments or creams (from viscous to cut-resistant) or lotions (from thin).

[0006] Emulsions have excellent cosmetic properties: the lipophilic components are absorbed relatively quickly into the skin, while the aqueous components sustainably increase skin moisture.

[0007] The properties of a cosmetic emulsion depend largely on the emulsifiers used. Among the oldest known emulsifiers are soaps, such as sodium stearate.

[0008] However, conventional emulsion-based cosmetic preparations have a number of disadvantages: Many of these preparations contain emulsifier systems and oil-phase components derived from crude oil (e.g., mineral oils, petrolatum), fully synthetically produced (e.g., silicone oils), and, in the eyes of many consumers, are not of "natural" origin. Furthermore, these compounds often have the disadvantage of being poorly and insufficiently biodegradable. However, many consumers desire to use so-called "natural cosmetics" (which generally refers to cosmetics with emulsifier systems and oil-phase components derived from plants or animals).Although there are a number of products on the market which consumers understand to be "natural cosmetics", these preparations regularly have the disadvantage that the cosmetic and sensory properties (for example the rapid "absorption" of the preparation into the skin, low shine, low stickiness) leave something to be desired, that cosmetic active ingredients can only be incorporated inadequately (i.e. in an ineffective amount) and / or the stability (both storage, temperature and microbial stability) as described in EP 1 072 248 A2 is inadequate and that the formulations have an undesirable odour due to decomposition phenomena or a lack of purity.

[0009] The object of the present invention was therefore to eliminate the disadvantages of the prior art and to develop stable, cosmetically / sensorially attractive emulsion bases that are considered "natural cosmetics" by consumers and that do not require mineral oils and / or silicone oils without compromising cosmetic / sensory properties and stability. The formulations should be readily biodegradable and, at the same time, preservable with reduced amounts of preservatives.

[0010] A further disadvantage of emulsions containing mineral oils and / or petrolatum in the oil phase is that these preparations can lead to heat build-up and (associated) pimple formation in particularly sensitive individuals after application to the skin.

[0011] It was therefore a further object of the present invention to develop a cosmetic emulsion in which the risk of heat build-up and pimple formation is reduced compared to the prior art.

[0012] Another disadvantage of emulsions containing silicone oil is that these preparations have only low skin care performance and do not properly support skin moisturizing.

[0013] It was therefore the object of the present invention to develop an emulsion with a skin feel as is known from silicone oil-containing preparations, which ensure higher skin care performance and in particular higher skin moisturizing.

[0014] Surprisingly, the tasks are solved by a cosmetic preparation containing a) Glyceryl stearate citrate and b) 2-Propylheptyloctanoate.

[0015] Although the person skilled in the art is familiar with WO 2006 / 097235, which describes the use of esters of 2-propylheptanol in cosmetic preparations, this document could not point the way to the present invention.

[0016] The 2-propylheptyloctanoate according to the invention has the following structure:

[0017] Glyceryl stearate citrate (2-hydroxy-1,2,3-propanetricarboxylic acid 1,2,3-propanetriol monooctadecanoate, INCI Glyceryl Stearate Citrate, CAS 39175-72-9) is the citric acid ester of glyceryl stearate and is commercially available from Hüls Sasol under the name Imwitor 370, among others.

[0018] It is advantageous according to the invention if the preparation according to the invention contains glyceryl stearate citrate in a concentration of 0.1 to 10% by weight, based on the total weight of the preparation.

[0019] It is preferred according to the invention if the preparation according to the invention contains glyceryl stearate citrate in a concentration of 0.5 to 5% by weight, based on the total weight of the preparation.

[0020] It is advantageous according to the invention if the preparation contains 2-propylheptyloctanoate in a concentration of 0.5 to 25% by weight, based on the total weight of the preparation.

[0021] It is preferred according to the invention if the preparation contains 2-propylheptyloctanoate in a concentration of 1 to 15% by weight, based on the total weight of the preparation.

[0022] Advantageous embodiments of the present invention are characterized in that the preparation contains one or more emulsifiers having an HLB value of less than 8. In such cases, it is advantageous according to the invention if the preparation contains one or more emulsifiers having an HLB value of less than 8 in a total concentration of 0.1 to 3% by weight, based on the total weight of the preparation.

[0023] According to the invention, it is preferred if sorbitan isosterarate, cetyldimethicone copolyol and / or polyglyceryl-2 dipolyhydroxystearate is used as an emulsifier with an HLB value of less than 8.

[0024] It is advantageous according to the invention if the preparation contains one or more further UV filters selected from the group of the compounds phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)benzene and its salts; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2'-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]-phenol; 3-(4-methylbenzylidene)camphor; 3-benzylidene camphor; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid; 4-(Dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(Dimethylamino)benzoic acid amyl ester; 4-Methoxybenzalmalonic acid di(2-ethylhexyl) ester; 4-Methoxycinnamic acid (2-ethylhexyl) ester; 4-Methoxycinnamic acid isoamyl ester;2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-methoxy-4'-methylbenzophenon; 2,2'-Dihydroxy-4-methoxybenzophenon; 2-(4'-Diethylamino-2'-hydoxybenzoyl)-benzoesäurehexylester, 4-(tert.-Butyl)-4'-methoxydibenzoylmethan; Homomenthylsalicylat; 2-Ethylhexyl-2-hydroxybenzoat; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat; Dimethicodiethylbenzalmalonat; 3-(4-(2,2-bis Ethoxycarbonylvinyl)-phenoxy)propenyl)-methoxysiloxan / Dimethylsiloxan - Copolymer; 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazin (INCI :Bis-Ethylhexyloxyphenol Methoxyphenyl Triazin); Dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone); 2,4-bis-[5-1 (dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazin mit der (CAS Nr. 288254-16-0); 4,4',4"-(1,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris(2-ethylhexylester) (auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazin (INCI: Ethylhexyl Triazone);Titanium dioxide, zinc oxide, merocyanines selected from the group of compounds in a concentration of 0.01 to 40% by weight based on the total weight of the preparation.;

[0025] Advantageous embodiments of the present invention are characterized in that the preparation contains, as further ingredients, one or more compounds selected from the group of compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1,16-dicarboxylic acid, glyceryl glycose, (2-hydroxyethyl)urea, vitamin E or its derivatives and / or licochalcone A.

[0026] Such active ingredients can be advantageously used in an individual concentration of 0.01 to 10% by weight, based on the total weight of the preparation.

[0027] The preparations according to the invention may furthermore advantageously also contain self-tanning substances, such as dihydroxyacetone and / or melanin derivatives in concentrations of 1% by weight up to 10% by weight, based on the total weight of the preparation.

[0028] Furthermore, the preparations according to the invention can advantageously also contain repellents for protection against mosquitoes, ticks, spiders, and the like. Examples of advantageous repellents are N,N-diethyl-3-methylbenzamide (trade name: Meta-delphene, "DEET"), dimethyl phthalate (trade name: Palatinol M, DMP), 1-piperidinecarboxylic acid 2-(2-hydroxyethyl)-1-methylpropyl ester, and in particular 3-(Nn-butyl-N-acetyl-amino)-propionic acid ethyl ester (available from Merck under the trade name Insekt Repellent® 3535). The repellents can be used individually or in combination.

[0029] Particularly advantageous preparations are also obtained when antioxidants are used as additives or active ingredients. According to the invention, the preparations advantageously contain one or more antioxidants. All antioxidants suitable or commonly used for cosmetic applications can be used as inexpensive, yet optional, antioxidants.

[0030] Formulations according to the invention, which contain, for example, known anti-wrinkle active ingredients such as flavonglycosides (in particular α-glycosylrutin), coenzyme Q10, vitamin E and / or derivatives and the like, are particularly advantageous for protecting against aesthetically unattractive skin changes such as those that occur with skin aging (such as dryness, roughness and the formation of dryness lines, itching, reduced lipid replenishment (e.g. after washing), visible vascular dilation (telangiectasias, cuperosis), flaccidity and the formation of wrinkles and fine lines, local hyper-, hypo- and abnormal pigmentation (e.g. age spots), increased susceptibility to mechanical stress (e.g. cracking) and the like) and fatigued skin. They are also advantageous for combating the appearance of dry or rough skin.

[0031] Water-soluble antioxidants, such as vitamins, e.g. ascorbic acid and its derivatives, can be used particularly advantageously within the meaning of the present invention.

[0032] Preferred antioxidants are also vitamin E and its derivatives as well as vitamin A and its derivatives.

[0033] The amount of antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30 wt.%, particularly preferably 0.05 to 20 wt.%, in particular 0.1 to 10 wt.%, based on the total weight of the preparation.

[0034] It is particularly advantageous if the cosmetic preparations according to the present invention contain cosmetic active ingredients, preferred active ingredients being antioxidants which can protect the skin from oxidative stress.

[0035] Moisturizers are substances or mixtures of substances which give cosmetic preparations the property of reducing the moisture loss of the stratum corneum (also called transepidermal water loss (TEWL)) and / or positively influencing the hydration of the stratum corneum after application or distribution on the skin surface.

[0036] Advantageous humectants (moisturizers) within the meaning of the present invention are, for example, glycerin, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccharide gum-1, glycine soya, ethylhexyloxyglycerin, pyrrolidonecarboxylic acid and urea. Furthermore, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gellatable polysaccharides. Particularly advantageous are, for example, hyaluronic acid, chitosan and / or a fucose-rich polysaccharide, which is filed in Chemical Abstracts under the registration number 178463-23-5 and is available, for example, under the name Fucogel®1000 from SOLABIA SA. Moisturizers can also be advantageously used as anti-wrinkle active ingredients to protect against skin changes, such as those caused by, for example, acne. B. occur during skin aging.

[0037] It is advantageous within the meaning of the present invention if the preparation according to the invention contains one or more humectants in a total concentration of 0.1 to 20% by weight and preferably in a total concentration of 0.5 to 10% by weight, in each case based on the total weight of the preparation.

[0038] The cosmetic preparations according to the invention may also advantageously, although not necessarily, contain fillers which, for example, further improve the sensory and cosmetic properties of the formulations and, for example, create or enhance a velvety or silky skin feel. Advantageous fillers within the meaning of the present invention are starch and starch derivatives (such as tapioca starch, distarch phosphate, aluminum or sodium starch octenylsuccinate, and the like), pigments which have neither a primarily UV-filtering nor coloring effect (such as boron nitride, etc.), and / or aerosils. ®(CAS No. 7631-86-9) and / or talc.

[0039] The aqueous phase of the preparations according to the invention can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those with a low carbon number, preferably ethanol and / or isopropanol, diols or polyols with a low carbon number and their ethers, preferably propylene glycol, 2-methylpropane-1,3-diol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, polymers, foam stabilizers, electrolytes, self-tanning agents and, in particular, one or more thickeners, which can advantageously be selected from the group consisting of silicon dioxide, aluminum silicates, polysaccharides and their derivatives, e.g.Hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose, particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of so-called Carbopols, for example Carbopol types 980, 981, 1382, 2984, 5984, individually or in combination. Further thickeners advantageous according to the invention are those with the INCI name Acrylates / C10-30 Alkyl Acrylate Crosspolymer (e.g., Pemulen TR 1, Pemulen TR 2, Carbopol 1328 from NOVEON) and Aristoflex AVC (INCI: Ammonium Acryloyldimethyltaurate / VP Copolymer).

[0040] It is preferred according to the invention if the preparation contains one or more diols selected from the group of the compounds 2-methyl-1,3-propanediol, pentane-1,2-diol, hexane-1,2-diol, heptane-1,2-diol, octane-1,2-diol, nonane-1,2-diol, decane-1,2-diol.

[0041] According to the invention, the preparation according to the invention advantageously contains film formers. Film formers within the meaning of the present invention are substances of various compositions that are characterized by the following property: If a film former is dissolved in water or other suitable solvents and the solution is then applied to the skin, it forms a film after the solvent evaporates, which essentially serves to fix the light filters to the skin and thus increase the water resistance of the product.

[0042] It is particularly advantageous to select film formers from the group of polymers based on polyvinylpyrrolidone (PVP). Particularly preferred are copolymers of polyvinylpyrrolidone, for example, PVP hexadecene copolymer and PVP eicosene copolymer, which are available from GAF Chemicals Cooperation under the trade names Antaron V216 and Antaron V220.

[0043] Also advantageous are other polymeric film formers, such as sodium polystyrene sulfonate, available under the trade name Flexan 130 from National Starch and Chemical Corp., and / or polyisobutene, available from Rewo under the trade name Rewopal PIB1000. Other suitable polymers include polyacrylamides (Seppigel 305), polyvinyl alcohols, PVP, PVP / VA copolymers, polyglycols, and acrylate / octylacrylamide copolymer (Dermacryl 79). Also advantageous is the use of hydrogenated castor oil dimer dilinoleate (CAS 646054-62-8, INCI Hydrogenated Castor Oil Dimer Dilinoleate), which can be purchased from Kokyu Alcohol Kogyo under the name Risocast DA-H, or PPG-3 benzyl ether myristate (CAS 403517-45-3), which can be purchased from Croda Chemicals under the trade name Crodamol STS.

[0044] The oil phase of the preparation according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, namely the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids with a chain length of 8 to 24, in particular 12 to 18, carbon atoms. The fatty acid triglycerides can advantageously be selected, for example, from the group of synthetic, semi-synthetic, and natural oils, such as cocoglyceride, olive oil, sunflower oil, jojoba oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grape seed oil, safflower oil, evening primrose oil, macadamia nut oil, and the like.

[0045] Also advantageous according to the invention are, for example, natural waxes of animal and plant origin, such as beeswax and other insect waxes as well as berry wax, shea butter and / or lanolin (wool wax).

[0046] Further advantageous polar oil components can be selected for the purposes of the present invention from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 3 to 30 C atoms and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 C atoms and from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 C atoms.Such ester oils can then advantageously be selected from the group phenethyl benzoate, 2-phenylethyl benzoate, isopropyl lauroyl sarcosinate, phenyl trimethicone, cyclomethicone, dibutyl adipate, octyl palmitate, octyl cocoate, octyl isostearate, octyldodeceyl myristate, octyldodecanol, cetearyl isononanoate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, stearyl heptanoate, oleyl oleate, oleyl erucate, erucyl oleate, Erucyl erucate, tridecyl stearate, tridecyl trimellitate, as well as synthetic, semi-synthetic and natural mixtures of such esters, such as jojoba oil.

[0047] Furthermore, the oil phase can advantageously be selected from the group of dialkyl ethers and dialkyl carbonates, for example, dicaprylyl ether (Cetiol OE) and / or dicaprylyl carbonate, for example that available under the trade name Cetiol CC from Cognis, are advantageous.

[0048] It is further preferred to select the oil component(s) from the group consisting of isoeicosane, neopentyl glycol diheptanoate, propylene glycol dicaprylate / dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, C 12-13 -Alkyl lactate, di-C 12-13 -Alkyl tartrate, triisostearin, dipentaerythrityl hexacaprylate / hexacaprate, propylene glycol monoisostearate, tricaprylin, dimethyl isosorbide. It is particularly advantageous if the oil phase of the formulations according to the invention contains C 12-15 -alkyl benzoate or consists entirely of it.

[0049] Advantageous oil components also include, for example, butyloctyl salicylate (available under the trade name Hallbrite BHB from CP Hall), tridecyl salicylate (available under the trade name Cosmacol ESI from Sasol), C12-C15 alkyl salicylate (available under the trade name Dermol NS from Alzo), hexadecyl benzoate and butyloctyl benzoate and mixtures thereof (Hallstar AB) and / or diethylhexyl naphthalate (Hallbrite TQ or Corapan TQ from Symrise).

[0050] Any mixtures of such oil and wax components can also be used advantageously within the meaning of the present invention.

[0051] According to the invention, the oil phase of the preparation according to the invention is advantageously free of silicone oils.

[0052] According to the invention, the oil phase of the preparation according to the invention is advantageously free from mineral oils, petroleum jelly and paraffin oil.

[0053] The cosmetic preparations according to the invention may contain cosmetic auxiliaries as are customarily used in such preparations, e.g. preservatives, preservative aids, complexing agents, bactericides, perfumes, substances for preventing or increasing foaming, dyes, pigments which have a coloring effect, thickeners, moisturizing and / or humectant substances, fillers which improve the feel of the skin, fats, oils, waxes or other customary components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.

[0054] It is advantageous according to the invention if the preparation contains one or more parabens (e.g. methyl-, ethyl-, propyl-, butylparaben).

[0055] Preparations for skin care are advantageous within the meaning of the present invention: they can serve as cosmetic sun protection and also as a make-up product in decorative cosmetics.

[0056] Depending on their structure, cosmetic compositions within the meaning of the present invention can be used, for example, as skin protection cream, day or night cream, etc. It is optionally possible and advantageous to use the compositions according to the invention as a basis for pharmaceutical formulations.

[0057] It is also advantageous within the meaning of the present invention to create cosmetic preparations whose primary purpose is not protection from sunlight, but which nevertheless contain UV-protective substances. For example, UV-A or UV-B filter substances are usually incorporated into day creams or makeup products. UV-protective substances, as well as antioxidants and, if desired, preservatives, also effectively protect the preparations themselves against deterioration. Cosmetic preparations in the form of a sunscreen are also advantageous.

[0058] According to the invention, in particular, the use of the preparation according to the invention for protection against skin aging (in particular for protection against UV-induced skin aging) and as a sunscreen.

[0059] According to the invention, the preparation according to the invention advantageously has a pH value of 5 to 8. This can be adjusted using conventional acids, bases, and buffer systems.

[0060] The preparation according to the invention can contain any mixtures of fragrances and perfumes in a wide variety of concentrations.

[0061] For use, the cosmetic preparations according to the invention are applied to the skin and / or hair in sufficient quantities in the manner customary for cosmetics. Examples

[0062] The following examples are intended to illustrate the present invention without limiting it. All data refer to weight percentages unless otherwise stated. emulsion A B C D E F G H Glyceryl Stearate Citrate 1,5 1,5 2 2,5 0,3 1,0 2,0 3,5 Sorbitan stearate 1,0 Cetearyl alcohol 2 1,5 Stearyl alcohol 2 1 Cetyl alcohol 3 Copolymer of vinylpyrrolidone and acrylic acid 0,5 1,0 1,6 0,3 Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0,3 2-Propylheptyloctanoate 5 3 7 10 8 2 9 3 C 12-15 Alkyl Benzoat 5 3 Butylene glycol dicaprylate / dicaprate 10 5 5 Dicaprylyl Ether Octyldodecanol 3 3 5 Dicaprylyl carbonate 5 2 Myristyl Myristate 1 2 Gaprylic / Capric Triglyceride 2 2 3 Isodecyl Neopentanoate ojoba oil 3 3 4 almond oil 2 2 Glycerin 2 5 10 5 7,5 4 2 1 Shea butter 3 Bis-ethylhexyloxyphenol methoxyphenyl triazine 2 1 2 Butyl Methoxydibenzoylmethan 2,5 3 2 5 Diethylamino Hydroxybenzoyl Hexyl Benzoate 1 4 Ethoxynexyl Methoxycinnamate 5 7,5 Octyl salicylate 4 5 I Ethylhexyltriazine 2 2 1 Diethylhexylbutamidotriazin 1 Octodecenedicarboxylic acid 1 Aluminum Starch Octenylsuccinate 1 Sodium Starch Octenylsuccinate 3 1 1,5 Tapioca starch 2 1 3 alcohol 0,5 3 5 Taurine 0,1 0,2 0,5 0,2 Folic acid 0,01 0,03 0,01 0,02 0,03 Vitamin E acetate 0,2 0,2 0,2 0,3 0,1 0,5 Na2H2EDTA 0,1 0,1 0,2 0,2 0,2 0,5 Perfume, preservatives qs qs qs qs qs qs qs qs Dyes, etc. qs qs qs qs qs qs qs qs Sodium hydroxide qs qs qs qs qs qs qs qs Water to 100.0 to 100.0 to 100.0 to 100.0 to 100.0 to 100.0 to 100.0 to 100.0 emulsion I K L M Glyceryl Stearate Citrate 2 2,5 2 3 Cetearyl alcohol 2 Stearyl alcohol 2 Cetyl alcohol 5 Xanthan gum 0,4 0,5 Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0,3 Carbomer 0,3 2-Propylheptyloctanoate 5 3 7 10 C 12-15 Alkyl Benzoat 2 Cocoglyceride 3 Isopropyl palmitate 4 Jojoba oil 2 5 Caprylic / Capric Triglyceride 2 almond oil 3 Glycerin 2 5 10 5 Shea butter 1 2 Sodium Starch Octenylsuccinate 3 Tapioca starch 2 alcohol 1 2 Creatine 1 Coenzyme Q10 0,1 0,2 Sodium ascorbyl phosphate 0,5 Na2H2EDTA 0,1 0,1 0,2 Perfume, preservatives qs qs qs qs Dyes, etc. qs qs qs qs Sodium hydroxide qs qs qs qs Water to 100.0 to 100.0 to 100.0 to 100.0

Claims

[1] Cosmetic preparation containing a) Glyceryl stearate citrate and b) 2-Propylheptyloctanoate. [2] Cosmetic preparation according to claim 1, characterized by that the preparation contains glyceryl stearate citrate in a concentration of 0.1 to 10% by weight, based on the total weight of the preparation. [3] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation contains 2-propylheptyl octanoate in a concentration of 0.5 to 25% by weight, based on the total weight of the preparation. [4] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation contains one or more emulsifiers with an HLB value of less than 8. [5] Cosmetic preparation according to one of the preceding claims, characterized bythat the preparation contains one or more further UV filters selected from the group of the compounds phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)benzene and its salts; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2'-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]-phenol; 3-(4-methylbenzylidene)camphor; 3-benzylidene camphor; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid; 4-(Dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(Dimethylamino)benzoic acid amyl ester; 4-Methoxybenzalmalonic acid di(2-ethylhexyl) ester; 4-Methoxycinnamic acid (2-ethylhexyl) ester; 4-Methoxycinnamic acid isoamyl ester; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone;2,2'-Dihydroxy-4-methoxybenzophenon; 2-(4'-Diethylamino-2'-hydoxybenzoyl)-benzoesäurehexylester, 4-(tert.-Butyl)-4'-methoxydibenzoylmethan; Homomenthylsalicylat; 2-Ethylhexyl-2-hydroxybenzoat; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat; Dimethicodiethylbenzalmalonat; 3-(4-(2,2-bis Ethoxycarbonylvinyl)-phenoxy)propenyl)-methoxysiloxan / Dimethylsiloxan - Copolymer; 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazin (INCI :Bis-Ethylhexyloxyphenol Methoxyphenyl Triazin); Dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone); 2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazin mit der (CAS Nr. 288254-16-0); 4,4',4"-(1,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris(2-ethylhexylester) (auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazin (INCI: Ethylhexyl Triazone);Titanium dioxide, zinc oxide, merocyanines selected from the group of compounds in a concentration of 0.01 to 40% by weight based on the total weight of the preparation.; [6] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation contains as further ingredients one or more compounds selected from the group of compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, tocopheryl acetate, dihydroxyacetone; 8-hexadecene-1,16-dicarboxylic acid, glyceryl glycose, (2-hydroxyethyl)urea, vitamin E or its derivatives and / or licochalcone A. [7] Cosmetic preparation according to one of the preceding claims, characterized bythat the preparation contains one or more emulsifiers with an HLB value of less than 8 in a total concentration of 0.1 to 3% by weight, based on the total weight of the preparation. [8] Cosmetic preparation according to one of the preceding claims, characterized by that sorbitan isosterarate, cetyl dimethicone copolyol and / or polyglyceryl-2 dipolyhydroxystearate is used as an emulsifier with an HLB value of less than 8. [9] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation contains one or more diols selected from the group of the compounds 2-methyl-1,3-propanediol, pentane-1,2-diol, hexane-1,2-diol, heptane-1,2-diol, octane-1,2-diol, nonane-1,2-diol, decane-1,2-diol. [10] Cosmetic preparation according to one of the preceding claims, characterized by that the preparation contains one or more parabens.